Is ADLM up or down today?
ADLM is down 0.70% today, last at 369.42. This stock moved -0.70% versus the prior close.
ADLM · ADLM
ADLM (ADLM) is trading at 369.42, down 0.70% on the session. Price signals are mixed — no clear one-way momentum read.
Over the past 7 days, 4 headlines skew mixed. Product/Launch and Analyst Rating themes dominated coverage. Stories with measurable price impact averaged -5.96% — headlines dragged the stock.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
ADLM is down 0.70% today, last at 369.42. This stock moved -0.70% versus the prior close.
Over the past 7 days, 4 headlines skew mixed. Product/Launch and Analyst Rating themes dominated coverage. Stories with measurable price impact averaged -5.96% — headlines dragged the stock. Dominant story: Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology - Arizona Daily Star (2 sources, neutral) RSI unavailable Price sits at 50% of its 52-week range Social (demo): 41% of recent mentions lean bullish — mixed social mood.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 11,617 mentions over 30d
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology - Arizona Daily Star
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology - malaysiasun.com
Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026 - BioSpace
Cepheid to Unveil Third-Generation GeneXpert® System at ADLM 2026, Advancing Molecular Diagnostic Capabilities | Newswise - newswise.com
Caresfield Unveils “The Resilience-Ready Lab” Initiative at ADLM 2026 to Combat Hemolysis and Supply Chain Shocks | Newswise - newswise.com